Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $44.7 million.

  • Haemonetics' Income towards Parent Company rose 1932.58% to $44.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $175.4 million, marking a year-over-year increase of 3486.37%. This contributed to the annual value of $167.7 million for FY2025, which is 4262.83% up from last year.
  • Per Haemonetics' latest filing, its Income towards Parent Company stood at $44.7 million for Q4 2025, which was up 1932.58% from $38.7 million recorded in Q3 2025.
  • Haemonetics' Income towards Parent Company's 5-year high stood at $58.0 million during Q1 2025, with a 5-year trough of -$11.0 million in Q2 2021.
  • Its 5-year average for Income towards Parent Company is $27.5 million, with a median of $32.1 million in 2022.
  • As far as peak fluctuations go, Haemonetics' Income towards Parent Company crashed by 16261.2% in 2021, and later surged by 54627.3% in 2022.
  • Over the past 5 years, Haemonetics' Income towards Parent Company (Quarter) stood at $14.8 million in 2021, then surged by 122.13% to $32.9 million in 2022, then fell by 5.15% to $31.2 million in 2023, then rose by 20.06% to $37.5 million in 2024, then increased by 19.33% to $44.7 million in 2025.
  • Its Income towards Parent Company was $44.7 million in Q4 2025, compared to $38.7 million in Q3 2025 and $34.0 million in Q2 2025.